Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 5/2018

01-11-2018 | Correction

Correction to: Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study

Authors: Kosei Matsue, Kyoya Kumagai, Isamu Sugiura, Takayuki Ishikawa, Tadahiko Igarashi, Tsutomu Sato, Michihiro Uchiyama, Toshihiro Miyamoto, Takaaki Ono, Yasunori Ueda, Toru Kiguchi, Yoshinori Sunaga, Toru Sasaki, Kenshi Suzuki

Published in: International Journal of Hematology | Issue 5/2018

Login to get access

Excerpt

The affiliation of the last author, Kenshi Suzuki has been incorrectly published in the original publication of the article. The correct affiliation is provided in this correction. …
Metadata
Title
Correction to: Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study
Authors
Kosei Matsue
Kyoya Kumagai
Isamu Sugiura
Takayuki Ishikawa
Tadahiko Igarashi
Tsutomu Sato
Michihiro Uchiyama
Toshihiro Miyamoto
Takaaki Ono
Yasunori Ueda
Toru Kiguchi
Yoshinori Sunaga
Toru Sasaki
Kenshi Suzuki
Publication date
01-11-2018
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 5/2018
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-018-2524-1

Other articles of this Issue 5/2018

International Journal of Hematology 5/2018 Go to the issue

Original Article

Clinical factors to predict outcome following mogamulizumab in adult T-cell leukemia-lymphoma

Original Article

Transfusion requirements and 30-day mortality predictors for adult hemophagocytic lymphohistiocytosis

Images in Hematology

Lymphadenopathy with coexisting normal architecture in malignant lymphoma

Original Article

Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study

Original Article

A phase 3b, multicenter, open-label extension study of the long-term safety of anagrelide in Japanese adults with essential thrombocythemia

Images in Hematology

Conspicuous activated lymphocytic proliferation associated with cytokine-release syndrome after CAR T-cell therapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits